TD Waterhouse Canada’s Akero Therapeutics AKRO Stock Holding History

TD Waterhouse Canada’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-700	Closed	-$32.6K	–	2044
2025 Q3	$32.6K	Sell	700 -680	-49%	-$32.9K	﹤0.01%	1293
2025 Q2	$70.9K	Buy	+1,380	New	+$62.7K	﹤0.01%	1042

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TD Waterhouse Canada's AKRO Position: Q4 2025 in Review

TD Waterhouse Canada sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 700 shares — an estimated $32.6K sold.

TD Waterhouse Canada first reported a position in AKRO in Q2 2025 and held it in 2 quarters. The position peaked at $70.9K in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

TD Waterhouse Canada reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
TD Waterhouse Canada sold 700 Akero Therapeutics shares in Q4 2025, an estimated $32.6K.
TD Waterhouse Canada first reported a position in Akero Therapeutics in Q2 2025 and held it in 2 quarters.
TD Waterhouse Canada's Akero Therapeutics position peaked at $70.9K in Q2 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on TD Waterhouse Canada's 13F filing for Q4 2025, filed 27 Jan 2026.